These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687 [TBL] [Abstract][Full Text] [Related]
6. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
7. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties. Farabaugh SM; Micalizzi DS; Jedlicka P; Zhao R; Ford HL Oncogene; 2012 Feb; 31(5):552-62. PubMed ID: 21706047 [TBL] [Abstract][Full Text] [Related]
8. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome. Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939 [TBL] [Abstract][Full Text] [Related]
9. Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain Cancers. Gardner L; Rossi J; Armstrong B; Muse M; LaVeck A; Blevins MA; Zhang L; Ford HL; Zhao R; Wang X ChemMedChem; 2024 Sep; 19(18):e202400179. PubMed ID: 38861151 [TBL] [Abstract][Full Text] [Related]
10. Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells. Anantharajan J; Zhou H; Zhang L; Hotz T; Vincent MY; Blevins MA; Jansson AE; Kuan JWL; Ng EY; Yeo YK; Baburajendran N; Lin G; Hung AW; Joy J; Patnaik S; Marugan J; Rudra P; Ghosh D; Hill J; Keller TH; Zhao R; Ford HL; Kang C Mol Cancer Ther; 2019 Sep; 18(9):1484-1496. PubMed ID: 31285279 [TBL] [Abstract][Full Text] [Related]
12. Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC. Zhang G; Dong Z; Prager BC; Kim LJ; Wu Q; Gimple RC; Wang X; Bao S; Hamerlik P; Rich JN JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30779712 [TBL] [Abstract][Full Text] [Related]
13. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells. Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621 [TBL] [Abstract][Full Text] [Related]
14. Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock. Dong Z; Zhang G; Qu M; Gimple RC; Wu Q; Qiu Z; Prager BC; Wang X; Kim LJY; Morton AR; Dixit D; Zhou W; Huang H; Li B; Zhu Z; Bao S; Mack SC; Chavez L; Kay SA; Rich JN Cancer Discov; 2019 Nov; 9(11):1556-1573. PubMed ID: 31455674 [TBL] [Abstract][Full Text] [Related]
15. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1. Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824 [TBL] [Abstract][Full Text] [Related]
16. The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor. Liu TZ; Wang X; Bai YF; Liao HZ; Qiu SC; Yang YQ; Yan XH; Chen J; Guo HB; Zhang SZ Int J Biochem Cell Biol; 2014 Apr; 49():8-16. PubMed ID: 24434023 [TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related]
18. Sorting nexin 10 sustains PDGF receptor signaling in glioblastoma stem cells via endosomal protein sorting. Gimple RC; Zhang G; Wang S; Huang T; Lee J; Taori S; Lv D; Dixit D; Halbert ME; Morton AR; Kidwell RL; Dong Z; Prager BC; Kim LJ; Qiu Z; Zhao L; Xie Q; Wu Q; Agnihotri S; Rich JN JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795488 [TBL] [Abstract][Full Text] [Related]
19. Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1. Bageritz J; Puccio L; Piro RM; Hovestadt V; Phillips E; Pankert T; Lohr J; Herold-Mende C; Lichter P; Goidts V Cell Death Differ; 2014 Jun; 21(6):929-40. PubMed ID: 24531536 [TBL] [Abstract][Full Text] [Related]
20. Aberrant hypomethylation and overexpression of the eyes absent homologue 2 suppresses tumor cell growth of human lung adenocarcinoma cells. Gao T; Zheng S; Li Q; Ran P; Sun L; Yuan Y; Xiao C Oncol Rep; 2015 Nov; 34(5):2333-42. PubMed ID: 26329363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]